eNeura Therapeutics Funding: $17M Raised, Series D (2018)
eNeura Therapeutics is based in Washington, D.C.. It has raised $17M in total funding. Latest round: Series D. Backed by Catalio Capital Management.
eNeura Therapeutics funding overview
eNeura Therapeutics is based in Washington, D.C.. eNeura Therapeutics has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series D announced in February 2018. The round record for eNeura Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Catalio Capital Management.
eNeura Therapeutics at a glance
Total raised
$17M
Latest round
Series D
Latest round date
February 2018
Headquarters
Washington, D.C.
Notable investors
Catalio Capital Management
Frequently asked about eNeura Therapeutics funding
How much has eNeura Therapeutics raised?
eNeura Therapeutics has raised $17M in total disclosed funding across the rounds on record.
Who has invested in eNeura Therapeutics?
Catalio Capital Management are named among the investors backing eNeura Therapeutics.
What was the latest eNeura Therapeutics funding round?
The most recent disclosed round is a Series D, announced in February 2018.
Where is eNeura Therapeutics based?
eNeura Therapeutics is based in Washington, D.C..
When did eNeura Therapeutics last raise?
The last disclosed eNeura Therapeutics round closed in February 2018 at Series D.
We update the eNeura Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Washington and their backers are listed below.
